| Trial ID: | L0029 |
| Source ID: | NCT02213224
|
| Associated Drug: |
Telmisartan
|
| Title: |
Perindopril and Telmisartan for the Treatment of Nonalcoholic Fatty Liver Disease
|
| Acronym: |
NF-NAFLD
|
| Status: |
Unknown status
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Nonalcoholic Fatty Liver Disease (NAFLD)
|
| Interventions: |
Drug: Perindopril|Drug: Telmisartan|Drug: Amlodipine
|
| Outcome Measures: |
Cap value of FibroScan ???dB/m???|Angiotensin II|IL-18???IL-1??|aminotransferase|lipids|HOMA-IR|computed tomography value of liver
|
| Sponsor/Collaborators: |
Nanfang Hospital of Southern Medical University
|
| Gender: |
All
|
| Age: |
18 Years to 70 Years ?? (Adult, Older Adult)
|
| Phases: |
Phase 4
|
| Enrollment: |
180
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment
|
| Start Date: |
August 2014
|
| Completion Date: |
September 2017
|
| Results First Posted: |
--
|
| Last Update Posted: |
August 11, 2014
|
| Locations: |
Nanfang Hospital, Southern Medical University, GuangZhou, Guangdong, China
|
| URL: |
https://ClinicalTrials.gov/show/NCT02213224
|
